Predictors of Radiological and Clinical Disease Reactivation in Multiple Sclerosis Patients After Cessation of Natalizumab (Tysabri)
ABSTRACT Background and Purpose: Natalizumab (NTZ) is widely used for patients with highly active relapsing–remitting multiple sclerosis (RRMS), but its discontinuation can lead to disease reactivation, significantly impacting Middle Eastern populations. This study aimed to assess the frequency of d...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley
2025-09-01
|
| Serie: | Brain and Behavior |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1002/brb3.70904 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|